NICE chief: Approval changes 'won't increase NHS drugs bill'

By Nick Renaud-Komiya2014-03-27T09:37:00

The head of the National Institute of Health and Care Excellence has suggested the NHS will not pay more overall for branded pharmaceuticals in future as a result of proposed changes to the way the organisation assesses the value of new drugs.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here